<DOC>
	<DOCNO>NCT02173223</DOCNO>
	<brief_summary>A . To evaluate ocular hypotensive efficacy rho-kinase Inhibitor ( AR-12286 0.5 % 0.7 % ) ophthalmic solution glaucoma patient fail prior glaucoma filter surgery uncontrolled IOP face surgical intervention . Patients treat 6 month initial trial . B . To evaluate efficacy AR-12286 enabling treat patient delay avoid necessity surgical intervention .</brief_summary>
	<brief_title>A Study Assess Effect Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5 % 0.7 % Patients With Uncontrolled Advanced Glaucoma With Prior Failed Trabeculectomy Tube Shunt</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>1 . Patients older 18 year either sex . 2 . Patients openangle glaucoma prior glaucoma filter surgery . 3 . IOP target range visual field progression . 4 . Have give write informed consent , prior investigational procedure . 5 . Ability attend 6month duration treatment . 1 . Closed angle glaucoma ( primary secondary ) . 2 . Known hypersensitivity component formulation ( benzalkonium chloride , etc . ) , topical anesthetic . 3 . Ocular medication kind within 30 day baseline visit , exception ocular hypotensive medication and/or lubricate drop dry eye ( may use throughout study ) . 4 . Any abnormality prevent reliable applanation tonometry treat eye . 5 . Clinically significant systemic disease ( e.g. , uncontrolled diabetes , myasthenia gravis , hepatic , renal , endocrine cardiovascular disorder ) might interfere study . 6 . Participation investigational study within past 30 day . 7 . Inability perform reliable visual field test . 8 . Unwilling sign consent form approve Institutional Review Board ( IRB ) New York Eye Ear Infirmary . 9 . Selfreported poor compliance treatment . 10 . Reluctance return schedule followup visit . 11 . Patients able understand nature study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>